Press "Enter" to skip to content

CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer – Yahoo Finance

admin 0

CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer  Yahoo Finance

The Patent Covers the Use of Aldoxorubicin Intravenously, Intra-Arterially or Intramuscularly for the Treatment of Brain Cancer. LOS ANGELES, May 8, 2019 …

“colorectal cancer” – Google News

(Visited 18 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *